Logo-jnp
J Nephropathol. 2017;6(3): 240-247. doi: 10.15171/jnp.2017.39
PMID: 28975107        PMCID: PMC5607989

Original Article

Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study

Viviana Navarro-Rodríguez 1, Alvaro Herrera-Munoz 1, Adrián Castro 1, Allan Ramos-Esquivel 2 *

Cited by CrossRef: 6

1- Rezzouk B, Bouattar T, Belkadi B, Razine R, Bayahia R, Ouzeddoun N, Benamar L, Rhou H, Bouihat N, Ibrahimi A, Seffar M, Kabbaj H. Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco. TRRM. 2021;Volume 13:1 [Crossref]
2- Abou-Jaoudé M, El Hage S, Akiki D, Fadlallah M, Ghaith A, Dib A. Cytomegalovirus infection in kidney transplant patients: Prevalence, risk factors, and impact on outcome – A local multicentre experience. Transplant Immunology. 2021;69:101473 [Crossref]
3- Vankova O, Brusnigina N. Genotyping clinical cytomegalovirus isolates in solid-organs-transplant recipients. Russian Journal of Infection and Immunity. 2022;12(1):59 [Crossref]
4- Tang Y, Guo J, Li J, Zhou J, Mao X, Qiu T. Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis. Transplant Immunology. 2022;74:101677 [Crossref]
5- Gardiner B, Bailey J, Percival M, Morgan B, Warner V, Lee S, Morrissey C, Kaye D, Peleg A, Taylor A. Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients. Clinical Transplantation. 2023;37(6) [Crossref]